AEGLE THERAPEUTICS

Aegle Therapeutics is developing novel therapies using extracellular vesicles (EVs) isolated from mesenchymal stem cells (MSCs) to deliver therapeutic biomolecules to diseased and damaged cells to treat disorders with significant unmet medical need... Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those suffering from debilitating rare diseases, including dystrophic epidermolysis bullosa (DEB) and other severe dermatological disorders. Aegle's platform technology has the potential to treat a wide range of other therapeutic indications.

Primary location: Woburn United States